Canada: concerns over teleradiology outsourcing from patients' point of view
This article was originally published in Clinica
The availability of cheap outsourcing services for interpreting diagnostic images is putting patients' best interests at risk through blurring the line between business and medicine. So said Normand Laberge, CEO of the Canadian Association of Radiologists at the Canadian Medical Association's National Health Policy and Negotiations Conference recently. Although the service is essential for some regions in Canada that are facing staff shortages, rapid technological developments providing a growing number of effective interventions are pushing up the price of healthcare. As a result, "physicians become driven by business concerns rather than professional responsibilities" and may choose services by their price rather than their quality, he said.
You may also be interested in...
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.